The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2019

Filed:

Sep. 17, 2015
Applicants:

Universté DE Montréal, Montréal, Québec, CA;

British Columbia Cancer Agency Branch, Vancouver, British Columbia, CA;

Fred Hutchinson Cancer Research Center, Seattle, WA (US);

Inventors:

Guy Sauvageau, Montréal, CA;

Keith Richard Humphries, Vancouver, CA;

Hans-Peter Kiem, Seattle, WA (US);

Iman Fares, Montréal, CA;

Jalila Chagraoui, Montréal, CA;

Assignees:

UNIVERSITE DE MONTREAL, Montreal, Quebec, CA;

BRITISH COLUMBIA CANCER AGENCY BRANCH, Vancouver, British Columbia, CA;

FRED HUTCHINSON CANCER RESEARCH CENTER, Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C12N 5/0789 (2010.01); C12N 15/87 (2006.01); A61K 48/00 (2006.01); A61K 35/28 (2015.01); C07D 487/04 (2006.01); C07D 519/00 (2006.01); C07K 5/083 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 35/28 (2013.01); A61K 48/00 (2013.01); C07D 487/04 (2013.01); C07D 519/00 (2013.01); C07K 5/0806 (2013.01); C12N 5/0647 (2013.01); C12N 15/87 (2013.01); C12N 2501/999 (2013.01); C12N 2510/00 (2013.01); C12N 2740/15043 (2013.01);
Abstract

Methods and compositions for enhancing viral gene transfer, such as lentiviral gene transfer, and improving the efficacy of gene delivery to cells such as primitive hematopoietic cells, are described. These methods and compositions are based on the use of pyrimido[4,5-b]indole derivatives. Cell-based compositions and methods useful for therapeutic indications amenable to treatment with gene therapies, including hematopoietic stem cell therapies, are also described.


Find Patent Forward Citations

Loading…